Insulin Resistance and Insulin therapy

Insulin is a peptide hormone produced by the cells of the pancreatic islets of Langerhans that regulates blood glucose levels by aiding cellular glucose uptake, regulating carbohydrate, lipid, and protein metabolism, and encouraging cell division and proliferation through its mitogenic activities. Insulin resistance and its consequences are becoming more prominent as obesity and diabetes reach epidemic proportions in the developed world. Insulin resistance is described as a biological response that is diminished by a normal or elevated insulin level; traditionally, this refers to impaired sensitivity to insulin-mediated glucose disposal. Insulin resistance syndrome is a collection of anomalies and physical consequences that are more likely in people who are insulin resistant.

  1. Diagnosing diabetes
  2. Monitoring diabetes

    Related Conference of Insulin Resistance and Insulin therapy

    March 26-27, 2026

    7th Global summit on Diabetes and Endocrinology

    Amsterdam, Netherlands
    May 14-15, 2026

    7th World Summit on Diabetes

    Rome, Italy
    May 18-19, 2026

    57th Annual Congress on Endocrinology and Diabetes Research

    Aix-en-Provence, France
    June 22-23, 2026

    16th World Congress on Endocrinology and Diabetes

    Paris, France
    August 17-18, 2026

    4th World congress and Expo on Diabetes

    Toronto, Canada
    September 29-30, 2026

    22nd World Congress on Endocrinology & Diabetes

    Paris, France

    Insulin Resistance and Insulin therapy Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in